Memorandum Of Law In Support Of Defendant’S Motion To Seal: WHISTLEBLOWERS & RESEARCH, v. NATIONAL INSTITUTES OF HEALTH,
Summary
The National Institutes of Health (NIH) asks the court to seal portions of the plaintiff's opposition to its summary judgment motion and a portion of Exhibit C. NIH states that it learned from reading the opposition that it had inadvertently failed to redact two names it had redacted elsewhere, those of the Sequence Read Archive curator and a foreign researcher, which it withheld under FOIA Exemption 6. It argues that there is no public interest in the names and that the individuals have a substantial privacy interest. NIH asks that the material stay sealed pending a summary judgment ruling from Judge Brinkema. The memorandum says the plaintiff opposes the motion and is dated July 15, 2022.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Cite this document
“Memorandum Of Law In Support Of Defendant’S Motion To Seal: WHISTLEBLOWERS & RESEARCH, v. NATIONAL INSTITUTES OF HEALTH,.”
Original at archive.org. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/gov-uscourts-vaed-516270-44-0-09c6592ded/
, SHA-256 21b1b12faeb8dd036a1a812b15bd18833ea40360544921a354dc76044d66b4ed.Full text
Case 1:21-cv-01275-LMB-JFA Document 44 Filed 07/15/22 Page 1 of 5 PageID# 822
IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF VIRGINIA
Alexandria Division
EMPOWER OVERSIGHT )
WHISTLEBLOWERS & RESEARCH, )
)
Plaintiff, )
) Case No. 1:21-cv-1275 (LMB/JFA)
v. )
)
NATIONAL INSTITUTES OF HEALTH, )
)
Defendant. )
)
)
MEMORANDUM OF LAW IN SUPPORT OF DEFENDANT’S MOTION TO SEAL
For the reasons set forth in detail below, Defendant National Institutes of Health (“NIH”),
through undersigned counsel, moves the Court pursuant to Local Civil Rule 5(C), to seal portions of
Plaintiff’s Opposition to Defendant’s Motion for Summary Judgment (Dkt. 47) and a portion of one
of the accompanying exhibits (Exhibit C, Dkt. 47-3).
BACKGROUND
In this case brought pursuant to the Freedom of Information Act, 5 U.S.C. §§ 551–59 (2018)
(“FOIA”), Plaintiff Empower Oversight Whistleblowers & Research seeks documents from the
NIH, based on three separate FOIA requests. See Am. Compl. (Dkt. 16) ¶¶ 24-27. As a general
matter, the requests concern a foreign researcher’s submission of COVID-19 genetic sequences, and
subsequent request to withdraw those sequences, to the Sequence Read Archive (“SRA”), which is
hosted by an NIH component. 1 Def.’s Summ. J. Mem. (Dkt. 37) at 4 (hereafter “Def.’s Mem.”).
1
The Sequence Read Archive (“SRA”) is the largest publicly-available repository of high throughput
sequencing data. SRA, NAT’L LIB. OF MED., NAT’L CTR. FOR BIOTECH. INFO., available at
https://www.ncbi.nlm.nih.gov/sra (last accessed June 8, 2022) (“SRA website”). It is hosted by the
National Center for Biotechnology Information (“NCBI”) at the National Library of Medicine
(“NLM”). Id.
1
Case 1:21-cv-01275-LMB-JFA Document 44 Filed 07/15/22 Page 2 of 5 PageID# 823
Relevant here, NIH withheld, pursuant to FOIA’s personal privacy interests exemption, 5 U.S.C. §
552(b)(6), the names and email addresses of certain NIH employees, as well as the foreign researcher
whose data is at the center of Plaintiff’s request. Id. at 25-29.
NIH has moved for summary judgment. Relevant here, it argued that the names and email
address of certain NIH employees and the foreign researcher were properly withheld under
Exemption 6 to FOIA because release would be a “clearly unwarranted invasion of privacy.” Def.’s
Mem. at 25 (citing Solers v. Internal Revenue Serv., 827 F.3d 323, 332 (Fourth Circ. 2016)). There is no
public interest in these names, as neither “‘would shed light on an agency’s performance of its
statutory duties or otherwise let citizens know what their government is up to.’” Id. (quoting Solers,
827 F.3d at 332). Conversely, substantial privacy interests, like “‘avoiding embarrassment, retaliation
or harassment and intense scrutiny by the media that would likely follow disclosure’” favored
withholding the names. Id. (quoting Judicial Watch, Inc. v. U.S. Dep’t of State, 875 F. Supp. 2d 37, 46
(D.D.C. 2012)).
While reading Plaintiff’s Opposition to Defendant’s Motion for Summary Judgment (Dkt.
41), NIH learned for the first time that it inadvertently failed to redact two names it had otherwise
redacted elsewhere in its productions to Plaintiff. In its Opposition, Plaintiff appears to argue that
NIH has waived the protections of Exemption 6 by this inadvertent disclosure. Opp’n at 25. The
Opposition and Exhibit C (Dkt. 41-3) specifically states, without redaction, the two names—the
SRA curator and the foreign researcher.
However, NIH’s motion for summary judgment is still pending. This means Judge
Brinkema has not yet ruled on whether NIH appropriately applied Exemption 6 to shield these
2
Case 1:21-cv-01275-LMB-JFA Document 44 Filed 07/15/22 Page 3 of 5 PageID# 824
names from disclosure. Accordingly, NIH moves to seal the portions of Plaintiff’s Opposition and
Exhibit C that contain these names. 2
ARGUMENT
Public access to judicial records is “protected both by the common law and the First
Amendment.” Stone v. Univ. of Md. Med. Sys. Corp., 855 F.2d 178, 180 (4th Cir. 1988). “The common
law presumes a right of the public to inspect and copy ‘all judicial records and documents.’” Id.
(quoting Nixon v. Warner Commc’ns, Inc., 435 U.S. 589, 597 (1978)).
However, the common law presumption in favor of public access can be overcome by a
showing that a litigant has “some significant interest that outweighs the presumption.” Rushford v.
New Yorker Magazine, Inc., 846 F.2d 249, 253 (4th Cir. 1988). Likewise, litigants can overcome the
First Amendment right of public access to documents by showing that “denial of access [is] . . .
necessitated by a compelling government interest and narrowly tailored to serve that interest.” Id.
Before ordering the sealing of documents, a court “must give the public notice of the request to seal
and a reasonable opportunity to challenge the request; it must consider less drastic alternatives to
sealing; and if it decides to seal it must state the reasons (and specific supporting findings) for its
decision and the reasons for rejecting alternatives to sealing.” Id.; see also Ashcraft v. Conoco, Inc., 218
F.3d 288, 302 (4th Cir. 2000). This Court has incorporated these “Ashcraft factors” into its local
rules. See LOC. CIV. R. 5. 3
2
NIH seeks to seal these materials unless and until Judge Brinkema determines that this information
is subject to disclosure, at which point NIH concedes this Court must revisit this issue.
3
Local Rule 5(C) requires that the party moving to seal documents provide:
(1) [a] non-confidential description of what is to be sealed; (2) [a] statement as to why
sealing is necessary, and why another procedure will not suffice; (3) [r]eferences to
governing case law; and (4) [u]nless permanent sealing is sought, a statement as to the
period of time the party seeks to have the matter maintained under seal and as to how
the matter is to be handled upon unsealing.
3
Case 1:21-cv-01275-LMB-JFA Document 44 Filed 07/15/22 Page 4 of 5 PageID# 825
NIH respectfully submits that all relevant standards, as well as the Ashcraft factors, are
satisfied by the circumstances presented here, and there is a “compelling government interest” that
outweighs the presumption of public access to portions of the Opposition and Exhibit C. Rushford,
846 F.2d at 253. First, by filing this public memorandum, Defendant has complied with the first
Ashcraft factor, which requires public notice and opportunity to comment. Plaintiff, who opposes
this motion, therefore has an opportunity to raise its objections with the Court.
Second, the materials should be sealed here unless and until Judge Brinkema finds the
information should be disclosed. NIH withheld the names of the SRA curator and the foreign
researcher who submitted the sequences, and then requested withdrawal, pursuant to 5 U.S.C. §
552(b)(6). Known as “Exemption 6,” this statutory provision safeguards from disclosure under
FOIA “personnel and medical files and similar files the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy[.]” 5 U.S.C. § 552(b)(6). As detailed in NIH’s
summary judgment brief, disclosure of these names does not reveal anything about how NIH
operates, i.e., there is no public interest in learning these names. Def.’s Mem. at 26, 28-30.
Conversely, the individuals have a substantial privacy interest in avoiding harassment or media
scrutiny that would likely follow disclosure. Id. at 27-28, 30.
NIH inadvertently failed to redact the two names at issue on at least one page of its FOIA
productions to Plaintiff. 4 In opposing NIH’s summary judgment motion, Plaintiff appears to argue
that NIH has waived the protections of Exemption 6 because of this mistake. Opp’n at 25. That is
The rule also provides that the moving party must provide a proposed order reciting “the
findings required by governing case law to support the proposed sealing.” Id.
4
NIH is reviewing whether other materials leave unredacted the two names at issue. To its
knowledge, the only instances of the names appearing on the public docket are on one page of
Plaintiff’s Opposition and on one page of Exhibit C.
4
Case 1:21-cv-01275-LMB-JFA Document 44 Filed 07/15/22 Page 5 of 5 PageID# 826
incorrect. “[A]n agency’s inadvertent disclosure of individual names and other [personally
identifiable information] rarely waives privacy interests under Exemption 6 because those interests
belong to the individuals, not to the agency.” Amiri v. Nat’l Sci. Found., 2021 WL 4438910, at *8
(D.D.C. Sept. 28, 2021), aff’d, 2022 WL 1279740 (D.C. Cir. Apr. 28, 2022); see also Bartko v. U.S. Dep’t
of Justice, 167 F. Supp. 3d 55, 68 (D.D.C. 2016) (same, with respect to Exemption 7(C)). Plaintiff has
put forward no evidence that either individual has waived their privacy interests here. Sealing is
therefore necessary to protect this information from any further public dissemination, beyond that
which the Opposition and Exhibit C have already caused. This is the least drastic means available,
in that NIH seeks only to redact the small portions of Plaintiff’s Opposition and Exhibit C that
reveal the withheld information. Accordingly, NIH has met its burden to demonstrate sealing is
appropriate here. The Court should maintain the status quo and seal the portions of Plaintiff’s
Opposition and Exhibit C that reference these names, pending a summary judgment ruling from
Judge Brinkema requiring disclosure of these names.
CONCLUSION
For the foregoing reasons, NIH respectfully requests that the Court grants its motion to seal.
Dated: July 15, 2022 Respectfully submitted,
JESSICA D. ABER
UNITED STATES ATTORNEY
By: /s/
MEGHAN LOFTUS
Assistant United States Attorney
Office of the United States Attorney
Justin W. Williams U.S. Attorney’s Building
2100 Jamieson Ave.
Alexandria, VA 22314
Tel: (703) 299-3757
Fax: (703) 299-3983
Email: meghan.loftus@usdoj.gov
Counsel for Defendant
5File and source
- File
- gov.uscourts.vaed.516270.44.0.pdf
- Size
- 141,388 bytes
- SHA-256
- 21b1b12faeb8dd036a1a812b15bd18833ea40360544921a354dc76044d66b4ed
- Original
- archive.org